Airing frustrations with pharma, a Republican FTC commissioner just endorsed Medicare negotiation

16 January 2020 - A Republican member of the Federal Trade Commission on Thursday expressed support for allowing Medicare to ...

Read more →

U.S. targets drug pricing, no-poach deals for anti-trust action in 2020

15 January 2020 - Justice Department antitrust chief also promises decision on music licensing, criticizes states’ lawsuit against T-Mobile and Sprint. ...

Read more →

Reform at the FDA—in need of reform

14 January 2020 - On 23 December 2016, the US FDA announced the approval of nusinersen, the first drug for the ...

Read more →

Democrats zero in on high drug prices in Iowa debate

14 January 2020 - Until Tuesday, nearly every single Democratic primary debate has focused on the same health care issue: ...

Read more →

FDA approval and regulation of pharmaceuticals, 1983-2018

14 January 2020 - How has the regulation of prescription drugs evolved from the 1980s to 2018, and what trends have ...

Read more →

FDA approves drugs faster than ever but relies on weaker evidence, researchers find

14 January 2020 - The FDA has gotten faster at approving new prescription drugs over the past four decades, but ...

Read more →

Basket cases: how real-world testing for drugs approved based on basket trials might lead to false diagnoses, patient risks, and squandered resources

14 January 2020 - Basket trials, studies designed to assess the safety and efficacy of therapeutics targeted to a specific molecular ...

Read more →

TGA - 2019 in review

14 January 2020 - According to the TGA, it approved 34 new chemical entities in 2019. ...

Read more →

The Tories must learn from the Orkambi victory and keep drug-pricing off the table

12 January 2020 - To match its rhetoric on the NHS, the government has to legally commit to preventing drug-pricing being ...

Read more →

The FDA is in trouble. Here’s how to fix it.

11 January 2020 - Some New Year’s resolutions for the incoming boss. ...

Read more →

Start-up proposes ‘third way’ to cut US drug prices

12 January 2020 - Alexis Borisy secures $200 million funding for venture aiming to use ‘fast follow’ treatments. ...

Read more →

Lies, damn lies, and drug price increases

9 January 2020 - As each new year begins, drug manufacturers announce their changes to the list price of drugs.  ...

Read more →

Defending transparency at European drug regulator

8 January 2020 - Forthcoming judgment must uphold public access to clinical data ...

Read more →

FDA real world evidence to be made available on Google Cloud

8 January 2020 - The company is making the agency's open-source MyStudies platform available, enabling for easier access to data for ...

Read more →

California plan would upend drug prices, though obstacles abound

9 January 2020 - Newsom wants to create state-run wholesaler, pool buying power. ...

Read more →